Thomas Urban Marron, MD, PhD, Icahn School of Medicine at Mount Sinai and CRI Clinical Innovator, is an authority in the immunotherapy space with backgrounds both in research and medicine. CRI is proud to have him speak during this summit about lung cancer, a disease that is diagnosed in over 2M new patients every year worldwide. Dr. Marron contributes towards our greater understanding of lung cancer and novel treatments for the disease.
Immune to Cancer: The CRI Blog
Patient Immunotherapy Summit: Lung Cancer Brief
For media inquiries, please contact us at [email protected]
Stay up to date
Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.
